An informatics approach identifying markers of chemosensitivity in human cancer cell lines

Cancer Research

Volumn 60, Issue 21, 2000, Pages 6101-6110

  Amundson, S A ^a   Myers, T G ^a   Scudiero, D ^a   Kitada, S ^a   Reed, J C ^a   Fornace A J , Jr ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2 CHLOROETHYL) 3 (2,6 DIOXO 3 PIPERIDYL) 1 NITROSOUREA; 5 AZA 2' DEOXYCYTIDINE; ALKYLATING AGENT; AMSACRINE; ANTINEOPLASTIC AGENT; CAMPTOTHECIN; CARBOPLATIN; CARMUSTINE; CISPLATIN; COLCHICINE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; FLOXURIDINE; FLUOROURACIL; FOLIC ACID ANTAGONIST; HYDROXYUREA; LOMUSTINE; METHOTREXATE; MITOMYCIN C; PACLITAXEL; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL X; PROTEIN P53; TIOGUANINE; UNINDEXED DRUG; VINBLASTINE; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER RESISTANCE; CHEMOSENSITIVITY; CONTROLLED STUDY; CORRELATION FUNCTION; FACTORIAL ANALYSIS; HUMAN; HUMAN CELL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; BLOOD PROTEINS; CLUSTER ANALYSIS; DRUG SCREENING ASSAYS, ANTITUMOR; GENE EXPRESSION; HUMANS; MEDICAL INFORMATICS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034327411     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Feasibility of a high-flux anticancer drug screen using a diverse panel of cultured human tumor cell lines
2. The National Cancer Institute: Cancer drug discovery and development program
3. An information intensive approach to the molecular pharmacology of cancer
4. A protein expression database for the molecular pharmacology of cancer
5. cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses
6. Use of a cDNA microarray to analyse gene expression patterns in human cancer
7. An abnormality in the p53 pathway following γ-irradiation in many wild-type p53 human melanoma lines
8. Gadd45, a p53-responsive stress protein, modifies DNA accessibility on damaged chromatin
9. Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents
10. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
11. Estimation of relative mRNA content by filter hybridization to a polythymidylate probe
12. Genotoxic stress confers preferential and coordinate mRNA stability on the five gadd genes
13. Isolation and characterization of the hamster gadd153 gene. Activation of promoter activity by agents that damage DNA
14. Estimation of relative mRNA content by filter hybridization to a polyuridylic probe
15. Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses
16. Mammalian genes coordinately regulated by growth arrest signals and DNA-damaging agents
17. Genotoxic-stress-response genes and growth-arrest genes; the gadd, MyD, and other genes induced by treatments eliciting growth arrest
18. Induction of cellular p53 activity by DNA-damaging agents and growth arrest
19. p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation
20. Mammalian DNA damage-inducible genes associated with growth arrest and apoptosis
21. Induction of heat shock protein transcripts and B2 transcripts by various stresses in Chinese hamster cells
22. Ubiquitin mRNA is a major stress-induced transcript in mammalian cells
23. DNA damage-inducible transcripts in mammalian cells
24. Determination of nucleic acid sequence homologies and relative concentrations by a dot hybridization procedure
25. Induction of fos RNA by DNA-damaging agents
26. The p53-dependent γ-ray response of GADD45
27. Similarity of the DNA-damage responsiveness and growth-suppressive properties of WAF1 to GADD45
28. Myc represses the growth arrest gene gadd45
29. Myc suppresses induction of the growth arrest genes gadd34, gadd45 and gadd153 by DNA-damaging agents
30. WAF1, a potential mediator of p53 tumor suppression
31. 1 arrest and apoptosis
32. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo
33. Induction of BAX by genotoxic stress in human cells correlates with normal p53 status and apoptosis
34. A mammalian cell cycle checkpoint utilizing p53 and GADD45 is defective in ataxia telangiectasia
35. Sequence conservation and DNA damage-responsiveness of the mammalian gadd45 gene
36. Abrogation of p53 function affects the response of gadd genes to DNA base damaging agents and medium starvation
37. p53: Puzzle and paradigm
38. Regulation of p21(CIP1/WAF1) expression by cellular stress: p53-dependent and p53-independent mechanisms
39. 6-alkylguanine
40. Bcl-X(L) protects cancer cells from p53-mediated apoptosis
41. Bax-independent inhibition of apoptosis by Bcl-X(L)
42. Expression of Bcl-x(L) and loss of p53 can cooperate to overcome a cell cycle checkpoint induced by mitotic spindle damage
43. Identification of immunosuppressant-induced apoptosis in a murine B-cell line and its prevention by bcl-x but not bcl-2
44. Expression of bcl-x(L) can confer a multidrug resistance phenotype
45. Bcl-2 and Bcl-X(L) can differentially block chemotherapy-induced cell death
46. Modulation of apoptosis by endogenous Bcl-x(L) expression in MKN-45 human gastric cancer cells
47. The novel primary response gene MyD118 and proto-oncogenes myb, myc, and bcl2 modulate TGFβ1 induced apoptosis of myeloid leukemia cells
48. Ordering the cell death pathway. Differential effects of BCL2, an interleukin-1-converting enzyme family protease inhibitor, and other survival agents on JNK activation in serum/nerve growth factor-deprived PC12 cells
49. The apoptosis-associated γ-ray response of BCL-X(L) depends on normal p53 function
50. The p53 tumor suppressor gene
51. p53 Mutations in human cancers